Konner, J. A., Grabon, D. M., Gerst, S. R., Iasonos, A., Thaler, H., Pezzulli, S. D., . . . Aghajanian, C. A. (2011). Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer. American Society of Clinical Oncology.
Chicago ZitierstilKonner, Jason A., et al. Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer. American Society of Clinical Oncology, 2011.
MLA ZitierstilKonner, Jason A., et al. Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer. American Society of Clinical Oncology, 2011.